Lead Exposure, Genetics, and Osteoporosis Epidemiology - Full Text View

Lead Exposure, Genetics, and Osteoporosis Epidemiology

This study has been completed.

Sponsored by:	National Institute of Environmental Health Sciences (NIEHS)
Information provided by:	National Institute of Environmental Health Sciences (NIEHS)
ClinicalTrials.gov Identifier:	NCT00013637

Purpose

This study's primary objective is to assess the effects of environmental lead exposures and genetic risk factors on the development of osteoporosis in middle-aged women.

Condition

Osteoporosis

MedlinePlus related topics:

Osteoporosis

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study

Further study details as provided by National Institute of Environmental Health Sciences (NIEHS):

Estimated Enrollment:	650
Study Start Date:	September 1998
Estimated Study Completion Date:	August 2003

Eligibility

Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Healthy participants in the Nurses' Health Study who live in the greater Boston metropolitan area.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00013637

Locations


United States, Massachusetts
	Brigham and Women's Hospital
	Boston, Massachusetts, United States, 02115

Sponsors and Collaborators

National Institute of Environmental Health Sciences (NIEHS)

More Information

Study ID Numbers:	8074-CP-001
First Received:	March 26, 2001
Last Updated:	September 1, 2006
ClinicalTrials.gov Identifier:	NCT00013637
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Environmental Health Sciences (NIEHS):

Osteoporosis

Lead

Study placed in the following topic categories:

Musculoskeletal Diseases

Osteoporosis

Bone Diseases, Metabolic

Bone Diseases

ClinicalTrials.gov processed this record on October 10, 2008